July 11, 2025CorporateTerumo Blood and Cell Technologies Demonstrates Integrated 3-in-1 CAR-T Workflow Using its Quantum Platform
July 02, 2025CorporateTERUMO ANNOUNCES COMMERCIAL LAUNCH OF THE IMMUCISE™ INTRADERMAL INJECTION SYSTEM
Top Management Message Message from top management to shareholders and investors. /investors/management/message Corporate Governance /about/governance Compliance /about/compliance Leadership Team /about/leadership Business Risks Major risks that may affect the business performance and financial position of the Terumo Group are described. /investors/management/risk IR Policy /investors/management/ir_policy Disclaimer /investors/disclaimer
